Master regulators of FGFR2 signalling and breast cancer risk
نویسندگان
چکیده
The fibroblast growth factor receptor 2 (FGFR2) locus has been consistently identified as a breast cancer risk locus in independent genome-wide association studies. However, the molecular mechanisms underlying FGFR2-mediated risk are still unknown. Using model systems we show that FGFR2-regulated genes are preferentially linked to breast cancer risk loci in expression quantitative trait loci analysis, supporting the concept that risk genes cluster in pathways. Using a network derived from 2,000 transcriptional profiles we identify SPDEF, ERα, FOXA1, GATA3 and PTTG1 as master regulators of fibroblast growth factor receptor 2 signalling, and show that ERα occupancy responds to fibroblast growth factor receptor 2 signalling. Our results indicate that ERα, FOXA1 and GATA3 contribute to the regulation of breast cancer susceptibility genes, which is consistent with the effects of anti-oestrogen treatment in breast cancer prevention, and suggest that fibroblast growth factor receptor 2 signalling has an important role in mediating breast cancer risk.
منابع مشابه
Vignette for Fletcher2013b: master regulators of FGFR2 signalling and breast cancer risk
2 Network inference and analysis 2 2.1 Data sources for regulatory network inference . . . . . . . . . . . . . . . . . . . . . . 2 2.2 Reconstruction of the breast cancer transcription networks . . . . . . . . . . . . . . . 2 2.2.1 Transcription network inference pipeline . . . . . . . . . . . . . . . . . . . . . 2 2.2.2 Pre-processing of gene expression data . . . . . . . . . . . . . . . . . ....
متن کاملFGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
The fibroblast growth factor receptor 2 (FGFR2) locus is consistently the top hit in genome-wide association studies for oestrogen receptor-positive (ER(+)) breast cancer. Yet, its mode of action continues to be controversial. Here, we employ a systems biology approach to demonstrate that signalling via FGFR2 counteracts cell activation by oestrogen. In the presence of oestrogen, the oestrogen ...
متن کاملActivating Somatic FGFR2 Mutations in Breast Cancer
It is known that FGFR2 gene variations confer a risk for breast cancer. FGFR2 and FGF10, the main ligand of FGFR2, are both overexpressed in 5-10% of breast tumors. In our study, we sequenced the most important coding regions of FGFR2 in somatic tumor tissue of 140 sporadic breast cancer patients and performed MLPA analysis to detect copy number variations in FGFR2 and FGF10. We identified one ...
متن کاملFunctional Analysis of a Breast Cancer-Associated FGFR2 Single Nucleotide Polymorphism Using Zinc Finger Mediated Genome Editing
Genome wide association studies have identified single nucleotide polymorphisms (SNP) within fibroblast growth factor receptor 2 (FGFR2) as one of the highest ranking risk alleles in terms of development of breast cancer. The potential effect of these SNPs, in intron two, was postulated to be due to the differential binding of cis-regulatory elements, such as transcription factors, since all th...
متن کاملGeographical Distribution of Breast Cancer in Hamadan Province during 2008-2015 Using Bayesian Method
Background and Objectives: Breast cancer has the highest incidence in the Iranian women. Methods: A cross-sectional study was conducted. All female with breast cancer during 2008-2015 were enrolled. Breast cancer registration is based on the pathology method in Iran. The information about female with breast cancer was collected from their files in the cancer registry department of Hamadan H...
متن کامل